Wegovy 1 mg FlexTouch is a once-weekly injectable prescription medicine used for chronic weight management. It contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist, and is delivered via the user-friendly FlexTouch pre-filled pen.

Uses:

Wegovy is indicated for chronic weight management in:

• Adults with obesity (BMI ≥30), or
• Adults who are overweight (BMI ≥27) with at least one weight-related condition such as:
  • Type 2 diabetes
  • Hypertension (high blood pressure)
  • Dyslipidemia (high cholesterol)

Used in combination with a reduced-calorie diet and increased physical activity.

Benefits:

• Proven to help reduce body weight over time
• Helps control appetite and cravings
• Improves markers of metabolic health (e.g., glucose levels, blood pressure)
• Once-weekly injection enhances treatment adherence
• Easy-to-use FlexTouch pen simplifies administration

Side Effects:

Common side effects:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Headache
• Dizziness
• Fatigue
• Indigestion or abdominal pain

Serious but rare side effects:

• Inflammation of the pancreas (pancreatitis)
• Gallbladder problems (e.g., gallstones)
• Kidney issues from dehydration
• Possible thyroid tumors (including medullary thyroid carcinoma)

Contraindications:
Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or MEN 2 (Multiple Endocrine Neoplasia syndrome type 2).

Storage:

• Before first use: Store in the refrigerator at 2°C to 8°C (36°F to 46°F)
• Do not freeze. Discard if frozen.
• Protect from light and heat
• Keep out of reach of children